FLT3 and leukemia: Healthy non‐leukemic CD34+ cells and other leukemia cell lines with wild‐type FLT3 exhibited no induction of AXL protein levels when treated with FLT3 TKI, even with differing basal AXL levels across the different cells (Fig. S1E).